- Home
- KLRS vs MNY Comparison
KLRS vs MNY Comparison
Compare KLRS & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- MNY
- Stock Information
- Founded
- KLRS 2019
- MNY 2014
- Country
- KLRS United States
- MNY Singapore
- Employees
- KLRS N/A
- MNY N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- MNY
- Sector
- KLRS Health Care
- MNY
- Exchange
- KLRS Nasdaq
- MNY Nasdaq
- Market Cap
- KLRS 46.0M
- MNY 43.9M
- IPO Year
- KLRS N/A
- MNY N/A
- Fundamental
- Price
- KLRS $2.56
- MNY $1.88
- Analyst Decision
- KLRS Buy
- MNY Strong Buy
- Analyst Count
- KLRS 1
- MNY 1
- Target Price
- KLRS N/A
- MNY $4.00
- AVG Volume (30 Days)
- KLRS 45.1K
- MNY 155.4K
- Earning Date
- KLRS 08-13-2025
- MNY 09-18-2025
- Dividend Yield
- KLRS N/A
- MNY N/A
- EPS Growth
- KLRS N/A
- MNY N/A
- EPS
- KLRS N/A
- MNY N/A
- Revenue
- KLRS N/A
- MNY $71,649,746.00
- Revenue This Year
- KLRS N/A
- MNY $16.97
- Revenue Next Year
- KLRS N/A
- MNY $19.35
- P/E Ratio
- KLRS N/A
- MNY N/A
- Revenue Growth
- KLRS N/A
- MNY N/A
- 52 Week Low
- KLRS $2.14
- MNY $0.55
- 52 Week High
- KLRS $24.15
- MNY $2.15
- Technical
- Relative Strength Index (RSI)
- KLRS 49.38
- MNY 57.53
- Support Level
- KLRS $2.37
- MNY $1.68
- Resistance Level
- KLRS $2.58
- MNY $2.02
- Average True Range (ATR)
- KLRS 0.18
- MNY 0.19
- MACD
- KLRS 0.01
- MNY -0.03
- Stochastic Oscillator
- KLRS 64.32
- MNY 59.09
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.